Translational Development Acquisition 

$1.6700
13
+$0.17+11.33% 16:39 Today

Statistics

Day High
1.59
Day Low
1.5601
52W High
1.67
52W Low
1.5601
Volume
741
Avg. Volume
-
Mkt Cap
32.25M
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TDACW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Translational Development Acquisition Corp., established in 2022 and headquartered in New York, New York, currently possesses no significant business operations. Its primary objective is to finalize a strategic business combination, which could involve a merger, share exchange, asset acquisition, or reorganization, with one or more other entities.
Show more...
CEO
Michael Hoffman
Employees
2
Country
United States
ISIN
KYG9008W1134

Listings

0 Comments

Share your thoughts

FAQ

What is Translational Development Acquisition stock price today?
The current price of TDACW is $1.67 USD — it has increased by +11.33% in the past 24 hours. Watch Translational Development Acquisition stock price performance more closely on the chart.
What is Translational Development Acquisition stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Translational Development Acquisition stocks are traded under the ticker TDACW.
What is Translational Development Acquisition market cap?
Today Translational Development Acquisition has the market capitalization of 32.25M
How many employees does Translational Development Acquisition have?
As of August 27, 2026, the company has 2 employees.
In which sector is Translational Development Acquisition located?
Translational Development Acquisition operates in the Finance & Payments sector.
When did Translational Development Acquisition complete a stock split?
Translational Development Acquisition has not had any recent stock splits.
Where is Translational Development Acquisition headquartered?
Translational Development Acquisition is headquartered in NEW YORK, United States.